Biochemical assessment of bone resorption and formation

Bone

Volumn 18, Issue 1 SUPPL., 1996, Pages S15-S16

  Marcus, Robert ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; COLLAGEN TYPE 1; HYDROXYPROLINE; OSTEOCALCIN; PYRIDINOL;

BONE REMODELING; COLLAGEN METABOLISM; CONFERENCE PAPER; HUMAN; HYDROXYPROLINE URINE LEVEL; OSSIFICATION; OSTEOBLAST; OSTEOLYSIS;

EID: 0030060859     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(95)00375-4     Document Type: Conference Paper

References (4)

1. Brown, J. P., Delmas, P. D., and Malaval, L. Serum bone Gla-protein: a specific marker for bone formation in postmenopausal osteoporosis. Lancet i: 1091-1093; 1984.
2. Delmas, P. D., Schlemmer, A., Gineyts, E., Riis, B., and Christiansen, C. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. J Bone Miner Res 6:639-644; 1991.
3. Lian, J. B. and Gundberg, C. M. Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Rel Res 226:267-291; 1988.
4. Prockop, O. J., Kivirikko, K. I., and Tuderman, K. The biosynthesis of collagen and its disorders. N Engl J Med 301:13-23; 1979.